Probentis Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Probentis General Information
Description
Developer of a medical diagnostic device designed for intraoperative detection of prostate cancer. The company's technology utilizes raman spectroscopy and laser-based tissue interrogation to identify molecular fingerprints, enabling urologists to detect cancerous tissue in real-time during surgical procedures.
Contact Information
Website
www.probentis.comCorporate Office
- 9A lan Morrison Road
- Hobsonville
- Auckland, 0616
- New Zealand
Corporate Office
- 9A lan Morrison Road
- Hobsonville
- Auckland, 0616
- New Zealand
Probentis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Aug-2026 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2026 | Completed | Startup |
Probentis Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Auckland UniServices | Corporate Venture Capital | Minority | ||
| Innovation Nexus | Accelerator/Incubator |
Probentis FAQs
-
When was Probentis founded?
Probentis was founded in 2025.
-
Where is Probentis headquartered?
Probentis is headquartered in Auckland, New Zealand.
-
What industry is Probentis in?
Probentis’s primary industry is Diagnostic Equipment.
-
Is Probentis a private or public company?
Probentis is a Private company.
-
What is Probentis’s current revenue?
The current revenue for Probentis is .
-
Who are Probentis’s investors?
Auckland UniServices and Innovation Nexus have invested in Probentis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process